June 23, 2018 8:08 PM ET

Pharmaceuticals

Company Overview of Watson Laboratories, Inc.

Company Overview

Watson Laboratories, Inc. manufactures pharmaceutical drugs. The company was incorporated in 1992 and is based in Corona, California. Watson Laboratories, Inc. operates as a subsidiary of ATeva Pharmaceutical Industries Limited.

132 Business Center Drive

Corona, CA 92880-1724

United States

Founded in 1992

Phone:

951-279-7158

Key Executives for Watson Laboratories, Inc.

Watson Laboratories, Inc. does not have any Key Executives recorded.

Watson Laboratories, Inc. Key Developments

The State of California Sues Watson Laboratories, Allergan Finance LLC, Activis Inc. and Allergan plc

The state of California has brought a lawsuit against units of Allergan plc and Teva Pharmaceutical Industries Ltd. Inc. alleging the pharmaceutical companies obstructed generic competition regarding the sale of Lidoderm. The unsealed, partially redacted, lawsuit filed Feb. 3 in federal court in San Francisco, claims that Allergan signed an agreement with Endo Pharmaceuticals Inc. promising that the company would not face any generic competition for Lidoderm from units of Allergan from May 2012 through September 2013 and in turn that Allergan would not face any competition from Endo until May 2014. The lawsuit termed the deal a 'pay-for-delay agreement'. The lawsuit names Watson Laboratories, now a subsidiary of Teva; Allergan Finance LLC, also known as Watson Pharmaceuticals Inc.; Activis Inc.; and Allergan plc. The action claims that as a result of the agreement, consumers had to pay hundreds of millions of dollars in surpa-competitive prices for prescriptions of Lidoderm as well as AB-rate generic equivalents from May 2012 for two years. The agreement with Allergan was critical for Endo since Lidoderm generated $825 million in revenues for Endo in 2011, and the entry of a generic competitor could have hit Endo hard. Allergan was set to introduce a generic version of the drug in 2012, but the signing of the agreement kept the drug on the sidelines, ensuring higher prices for Lidoderm. The 10-count legal action asks the court to judge the agreement to be a violation of the Sherman Act, constituting a restraint of trade, a conspiracy to monopolize trade, and that those ill-gotten gains be disgorged, and that the defendant companies pay $2,500 for each violation proven at trial.

US Federal Trade Commission Announces Lawsuit Filed against Watson and Allergan

Endo International and the US Federal Trade Commission resolved an FTC complaint that claimed Endo violated antitrust laws by using so-called pay-for-delay settlements that would block access to lower-cost generic versions of its Lidoderm and Opana ER drugs. In relation, the FTC refiled charges against Watson Laboratories and its former parent, Allergan for illegally blocking a lower-cost generic version of Lidoderm when it entered into a pay-for-delay agreement with Endo.

Similar Private Companies By Industry

Company Name Region
Praetego, Inc. United States
1st Order Pharmaceuticals, Inc. United States
21st Century Animal Health United States
3 Buds' Organics LLC United States
60° Pharmaceuticals, LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Watson Laboratories, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.